arrow_back Back to App

New Rules for Reporting Adverse Events from Abortion Drugs

This act introduces new requirements for healthcare providers and patients to report adverse events related to abortion drugs. The goal is to improve data collection on the safety of these medications, potentially affecting the availability of information on their use and potential health risks for women.
Key points
Healthcare providers must report any deaths or adverse events associated with abortion drugs to the FDA and manufacturers within 15 days.
Online portals will be established for both healthcare practitioners and patients to easily and confidentially report adverse events.
More data on prescribed abortion drugs, their shipment, deaths, and serious adverse events will be collected and published annually, increasing transparency.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6702
Sponsor: Rep. Walorski, Jackie [R-IN-2]
Process start date: 2022-02-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Safeguarding Women’s and Children’s Health Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6702.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-02-09.

What are the main provisions?

Key points include:

  • Healthcare providers must report any deaths or adverse events associated with abortion drugs to the FDA and manufacturers within 15 days.
  • Online portals will be established for both healthcare practitioners and patients to easily and confidentially report adverse events.
  • More data on prescribed abortion drugs, their shipment, deaths, and serious adverse events will be collected and published annually, increasing transparency.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Walorski, Jackie [R-IN-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health